VC DEALS ANALYSIS: Big-Buck Neurotech Investment Spikes February Takings
This article was originally published in Clinica
2016 may have started with a bang but deal value and volume levels look to be normalizing as we move towards the last leg of the first quarter.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.